Publication:
Short report: Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel

dc.contributor.authorSathit Pichyangkulen_US
dc.contributor.authorSomporn Krasaesuben_US
dc.contributor.authorAnan Jongkaewwattanaen_US
dc.contributor.authorArunee Thitithanyanonten_US
dc.contributor.authorSuwimon Wiboon-uten_US
dc.contributor.authorKosol Yongvanitchiten_US
dc.contributor.authorAmporn Limsalakpetchen_US
dc.contributor.authorUtaiwan Kum-Arben_US
dc.contributor.authorDuangrat Mongkolsirichaikulen_US
dc.contributor.authorNuanpan Khemnuen_US
dc.contributor.authorRangsini Mahanondaen_US
dc.contributor.authorJean Michel Garciaen_US
dc.contributor.authorCarl J. Masonen_US
dc.contributor.authorDouglas S. Walshen_US
dc.contributor.authorDavid L. Saundersen_US
dc.contributor.otherArmed Forces Research Institute of Medical Sciences, Thailanden_US
dc.contributor.otherThailand National Center for Genetic Engineering and Biotechnologyen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherHKU-Pasteur Research Centreen_US
dc.date.accessioned2018-11-09T02:26:50Z
dc.date.available2018-11-09T02:26:50Z
dc.date.issued2014-01-01en_US
dc.description.abstractWe studied cross-reactive antibodies against avian influenza H5N1 and 2009 pandemic (p) H1N1 in 200 serum samples from US military personnel collected before the H1N1 pandemic. Assays used to measure antibodies against viral proteins involved in protection included a hemagglutination inhibition (HI) assay and a neuraminidase inhibition (NI) assay. Viral neutralization by antibodies against avian influenza H5N1 and 2009 pH1N1 was assessed by influenza (H5) pseudotyped lentiviral particle-based and H1N1 microneutralization assays. Some US military personnel had cross-neutralizing antibodies against H5N1 (14%) and 2009 pH1N1 (16.5%). The odds of having cross-neutralizing antibodies against 2009 pH1N1 were 4.4 times higher in subjects receiving more than five inactivated whole influenza virus vaccinations than those subjects with no record of vaccination. Although unclear if the result of prior vaccination or disease exposure, these pre-existing antibodies may prevent or reduce disease severity. Copyright © 2014 by The American Society of Tropical Medicine and Hygiene.en_US
dc.identifier.citationAmerican Journal of Tropical Medicine and Hygiene. Vol.90, No.1 (2014), 149-152en_US
dc.identifier.doi10.4269/ajtmh.13-0151en_US
dc.identifier.issn00029637en_US
dc.identifier.other2-s2.0-84892779258en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34091
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84892779258&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleShort report: Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnelen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84892779258&origin=inwarden_US

Files

Collections